U. Winkler

989 total citations · 1 hit paper
12 papers, 785 citations indexed

About

U. Winkler is a scholar working on Immunology, Biotechnology and Molecular Biology. According to data from OpenAlex, U. Winkler has authored 12 papers receiving a total of 785 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 6 papers in Biotechnology and 4 papers in Molecular Biology. Recurrent topics in U. Winkler's work include Toxin Mechanisms and Immunotoxins (9 papers), Transgenic Plants and Applications (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). U. Winkler is often cited by papers focused on Toxin Mechanisms and Immunotoxins (9 papers), Transgenic Plants and Applications (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). U. Winkler collaborates with scholars based in Germany, United States and Italy. U. Winkler's co-authors include Volker Diehl, Andreas Engert, Oliver Manzke, Mark A. Jensen, H. Schulz, Claudia Gottstein, Andreas Engert, Heribert Bohlen, ML Hansmann and Stefan Barth and has published in prestigious journals such as Blood, Annals of Oncology and International Journal of Cancer.

In The Last Decade

U. Winkler

12 papers receiving 751 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal Antibody (Rituximab, IDEC-C2B8)

1999 516 citations U. Winkler, Mark A. Jensen et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
U. Winkler Germany	10	364	308	269	214	205	12	785
H Mellstedt Sweden	17	432 1.2×	161 0.5×	193 0.7×	190 0.9×	297 1.4×	36	874
N. Ciobanu United States	13	372 1.0×	99 0.3×	48 0.2×	285 1.3×	64 0.3×	24	672
DG Poplack United States	13	213 0.6×	68 0.2×	135 0.5×	262 1.2×	41 0.2×	22	716
Britta Maecker Germany	16	525 1.4×	116 0.4×	49 0.2×	398 1.9×	47 0.2×	22	875
Jean B. Robinson Canada	13	270 0.7×	157 0.5×	208 0.8×	153 0.7×	108 0.5×	22	832
Dominique Cazals France	9	98 0.3×	143 0.5×	40 0.1×	247 1.2×	82 0.4×	11	525
D Pettersson Sweden	17	390 1.1×	158 0.5×	284 1.1×	120 0.6×	263 1.3×	24	806
Carol Burian United States	9	303 0.8×	418 1.4×	605 2.2×	241 1.1×	23 0.1×	16	799
Ugo Consoli Italy	17	239 0.7×	102 0.3×	181 0.7×	395 1.8×	34 0.2×	36	863
Gerald L. Messerschmidt United States	12	166 0.5×	63 0.2×	56 0.2×	175 0.8×	43 0.2×	26	559

Countries citing papers authored by U. Winkler

Since Specialization

Citations

This map shows the geographic impact of U. Winkler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Winkler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Winkler more than expected).

Fields of papers citing papers by U. Winkler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Winkler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Winkler. The network helps show where U. Winkler may publish in the future.

Co-authorship network of co-authors of U. Winkler

This figure shows the co-authorship network connecting the top 25 collaborators of U. Winkler. A scholar is included among the top collaborators of U. Winkler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Winkler. U. Winkler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Schulz, H., U. Winkler, Jan Oliver Staak, & Andreas Engert. (2000). The Monoclonal Antibodies Campath-1H and Rituximab in theTherapy of Chronic Lymphocytic Leukemia. Oncology Research and Treatment. 23(6). 526–532. 11 indexed citations

2.

Winkler, U., Mark A. Jensen, Oliver Manzke, et al.. (1999). Cytokine-Release Syndrome in Patients With B-Cell Chronic Lymphocytic Leukemia and High Lymphocyte Counts After Treatment With an Anti-CD20 Monoclonal Antibody (Rituximab, IDEC-C2B8). Blood. 94(7). 2217–2224. 516 indexed citations breakdown →

3.

Jensen, Mark A., U. Winkler, Oliver Manzke, Volker Diehl, & Andreas Engert. (1998). Rapid tumor lysis in a patient with B-cell chronic lymphocytic leukemia and lymphocytosis treated with an anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab). Annals of Hematology. 77(1-2). 89–91. 81 indexed citations

4.

Schnell, R., E S Vitetta, John Schindler, et al.. (1998). Clinical Trials with an Anti-CD25 Ricin A-Chain Experimental and Immunotoxin (RFT5-SMPT-dgA) in Hodgkin's Lymphoma. Leukemia & lymphoma. 30(5-6). 525–538. 47 indexed citations

5.

Barth, Stefan, U. Winkler, Volker Diehl, & Andreas Engert. (1997). Immuntoxine. Der Internist. 38(11). 1063–1069. 1 indexed citations

6.

Winkler, U., Stefan Barth, R. Schnell, Volker Diehl, & Andreas Engert. (1997). The emerging role of immunotoxins in leukemia and lymphoma. Annals of Oncology. 8. S139–S146. 18 indexed citations

7.

Engert, Andreas, Claudia Gottstein, Heribert Bohlen, et al.. (1995). Cocktails of ricin a‐chain immunotoxins against different antigens on hodgkin and sternberg‐reed cells have superior anti‐tumor effects against H‐RS cells in vitro and solid Hodgkin tumors in mice. International Journal of Cancer. 63(2). 304–309. 27 indexed citations

8.

Gottstein, Claudia, U. Winkler, Heribert Bohlen, Volker Diehl, & Andreas Engert. (1994). Immunotoxins:Is there a clinical value?. Annals of Oncology. 5. S97–S103. 11 indexed citations

9.

Winkler, U., Claudia Gottstein, Gisela Schön, et al.. (1994). Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxins. Blood. 83(2). 466–475. 32 indexed citations

10.

Engert, Andreas, Claudia Gottstein, U. Winkler, et al.. (1994). Experimental Treatment of Human Hodgkin's Disease with Ricin A-Chain Immunotoxins. Leukemia & lymphoma. 13(5-6). 441–448. 13 indexed citations

11.

Winkler, U., Claudia Gottstein, Gisela Schön, et al.. (1994). Successful treatment of disseminated human Hodgkin's disease in SCID mice with deglycosylated ricin A-chain immunotoxins. Blood. 83(2). 466–475. 27 indexed citations

12.

Engert, Andreas, Claudia Gottstein, U. Winkler, et al.. (1992). [New perspectives in oncology: is selective destruction of tumor cells with immunotoxins in Hodgkin's disease an additional therapeutic alternative?].. PubMed. 87(10). 503–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact